Ads
related to: darzalex velcade and dexamethasone- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- About DARZALEX®
Learn About a Treatment Method and
How DARZALEX® Works
- Read Patient Stories
Learn About the Treatment Journey
From Real Patients & Caregivers
- Preparing For Treatment
Watch a Video About What to Expect
Before, During, & After Treatment
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- Sign Up for Support
Register With Janssen CarePath to
Receive Support Program Information
- DARZALEX® Side Effects
Search results
Results From The WOW.Com Content Network
Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. ... as well as with bortezomib and dexamethasone. ...
Bortezomib/dexamethasone is a combination drug against multiple myeloma. [1] When bortezomib is used by the trade name Velcade, the combination is called Vel/Dex (or Vel-Dex or Veldex ). Bortezomib is a proteasome inhibitor and dexamethasone is a corticosteroid .
It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]
GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late ...
For premium support please call: 800-290-4726 more ways to reach us
Sanofi plans to advance blood cancer drugs known as anti-CD38, which include Sarclisa, despite GenMab and Johnson & Johnson's strong foothold with Darzalex in the same class.
Ads
related to: darzalex velcade and dexamethasone